JP2023537093A5 - - Google Patents

Info

Publication number
JP2023537093A5
JP2023537093A5 JP2023509534A JP2023509534A JP2023537093A5 JP 2023537093 A5 JP2023537093 A5 JP 2023537093A5 JP 2023509534 A JP2023509534 A JP 2023509534A JP 2023509534 A JP2023509534 A JP 2023509534A JP 2023537093 A5 JP2023537093 A5 JP 2023537093A5
Authority
JP
Japan
Prior art keywords
promoter
composition according
wwox
wild
regulatory element
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023509534A
Other languages
English (en)
Japanese (ja)
Other versions
JP7850136B2 (ja
JP2023537093A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2021/050982 external-priority patent/WO2022034591A1/en
Publication of JP2023537093A publication Critical patent/JP2023537093A/ja
Publication of JP2023537093A5 publication Critical patent/JP2023537093A5/ja
Application granted granted Critical
Publication of JP7850136B2 publication Critical patent/JP7850136B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023509534A 2020-08-11 2021-08-11 Wwox関連疾患の治療方法 Active JP7850136B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063064181P 2020-08-11 2020-08-11
US63/064,181 2020-08-11
US202163167277P 2021-03-29 2021-03-29
US63/167,277 2021-03-29
PCT/IL2021/050982 WO2022034591A1 (en) 2020-08-11 2021-08-11 Method for the treatment of wwox associated diseases

Publications (3)

Publication Number Publication Date
JP2023537093A JP2023537093A (ja) 2023-08-30
JP2023537093A5 true JP2023537093A5 (cg-RX-API-DMAC7.html) 2024-08-20
JP7850136B2 JP7850136B2 (ja) 2026-04-22

Family

ID=77910831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023509534A Active JP7850136B2 (ja) 2020-08-11 2021-08-11 Wwox関連疾患の治療方法

Country Status (9)

Country Link
US (1) US20230293726A1 (cg-RX-API-DMAC7.html)
EP (2) EP4196595B1 (cg-RX-API-DMAC7.html)
JP (1) JP7850136B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230051223A (cg-RX-API-DMAC7.html)
AU (1) AU2021324538A1 (cg-RX-API-DMAC7.html)
CA (1) CA3188895A1 (cg-RX-API-DMAC7.html)
ES (1) ES3032462T3 (cg-RX-API-DMAC7.html)
IL (1) IL300374A (cg-RX-API-DMAC7.html)
WO (1) WO2022034591A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116463413B (zh) * 2023-06-12 2023-10-03 佛山科学技术学院 猪间性病相关的wwox基因分子标记及其应用
US20260069548A1 (en) * 2024-06-18 2026-03-12 Synaptec Network, Inc. Systems and Methods of Exosome Mediated Delivery of Antibodies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060811B2 (en) * 2000-10-13 2006-06-13 Board Of Regents, The University Of Texas System WWOX: a tumor suppressor gene mutated in multiple cancers
CA2624531A1 (en) * 2005-10-05 2007-04-19 Carlo M. Croce Wwox gene, vectors containing the same, and uses in treatment of cancer
MX2010011880A (es) * 2008-04-29 2011-05-25 Pharnext Nuevos enfoques terapeuticos para tratar la enfermedad del alzheimer y trastornos relacionados mediante una modulacion de la respuesta de estres celular.
EP2322163A1 (en) * 2009-11-03 2011-05-18 Pharnext New therapeutics approaches for treating alzheimer disease
CN105408483A (zh) 2013-03-15 2016-03-16 通用医疗公司 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向
WO2017147720A1 (en) * 2016-03-04 2017-09-08 Exerkine Corporation Method for treating a central nervous system disorder
MX2021000180A (es) * 2018-06-26 2021-06-08 Ribonova Inc Métodos para tratar la disfunción mitocondrial.
CA3160619A1 (en) * 2019-11-08 2021-05-14 Coave Therapeutics Modified adeno-associated virus vectors and delivery thereof into the central nervous system

Similar Documents

Publication Publication Date Title
AU2017227803B2 (en) Therapy for frontotemporal dementia
Zhang et al. The p21-activated kinases in neural cytoskeletal remodeling and related neurological disorders
JP2025120285A (ja) 繊毛病のための遺伝子治療
US20230002459A1 (en) Zinc Finger Protein Transcription Factors for Treatment of Prion Disease
US20230242602A1 (en) Zinc finger protein transcription factors for repressing tau expression
CN108884022A (zh) 用于治疗神经元的过度兴奋的方法和组合物
JP2021534206A5 (cg-RX-API-DMAC7.html)
US7060429B2 (en) Treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms
Rodriguez-Campuzano et al. Yin yang 1: function, mechanisms, and glia
TW202104249A (zh) 染色體9開放讀框72基因表現之調節子及其用途
JP2025516186A (ja) ミエリンの障害の治療
Kim et al. Application of neurotrophic factors as a therapeutic approach for neurodegenerative diseases
TWI888417B (zh) 用於抑制α-突觸核蛋白(SYNUCLEIN)表現之鋅指蛋白轉錄因子
Balasubramaniam et al. Analysis of age-dependant alteration in the brain gene expression profile following induction of hydrocephalus in rats
Sehara et al. Adeno-associated virus-mediated Ezh2 knockdown reduced the increment of newborn neurons induced by forebrain ischemia in gerbil dentate gyrus
US20240216537A1 (en) Gene therapy for neuroprotection
US20240018203A1 (en) Novel zinc finger protein transcription factors for repressing alpha-synuclein expression
RU2828216C2 (ru) Модуляторы экспрессии гена открытой рамки считывания 72 хромосомы 9 и их применения
KR20250109186A (ko) Nhr을 사용하는 신경학적 장애의 치료
WO1997041150A2 (en) Gene therapy for mitochondrial dna deffects using peptide nucleic acids
US20060148749A1 (en) Novel treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms
CN117377482A (zh) 用于神经保护的基因疗法
Vitro 765. The Feasibility of Herpes Simplex Virus Mediated Gene Therapy for Neurogenic Erectile Dysfunction
JP2007284410A (ja) 神経新生促進剤
HK1262485B (en) Method and composition for treating neuronal hyper-excitability